Category: Regulation and Deregulation of Industry

As Consumer Bureau’s Cash Dwindles, Trump Administration Declares Its Funding Illegal

The Justice Department embraced a novel conservative legal theory that it said blocked the Federal Reserve from funding the agency.
The I.R.S. Tried to Stop This Tax Dodge. Scott Bessent Used It Anyway.

Like many on Wall Street, Treasury Secretary Scott Bessent used a limited partnership to avoid Medicare taxes. Unlike the others, he’s now overseeing the I.R.S.
More Flight Troubles Expected Before the Shutdown Ends

Airlines brace for further chaos, even as eight Democratic senators broke ranks with their party to back a deal that could end the shutdown.
China Suspends Some Export Controls on Critical Minerals but Retains Others

The Chinese government followed through on promises it made publicly after a recent summit, but has not yet taken other actions sought by the White House.
What Trump’s New Drug Pricing Deal Means for People With Obesity

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.
France Blocks Orders From Shein as It Expands Its Crackdown

Customs officials were ordered to inspect more than 200,000 packages entering the country at Charles de Gaulle Airport.
Obesity Drugs May Drop to as Little as $150 a Month

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
How China’s Rare Earth Chokehold Could Strangle Europe’s Military Buildup

Drones, missiles and other crucial components of Europe’s rush to rearm itself rely on an increasingly unsteady supply of minerals from China.
Key Justices Cast a Skeptical Eye on Trump’s Tariffs

The Supreme Court is considering whether the president acted legally when he used a 1977 emergency statute to impose tariffs on scores of countries.
Trump Aides Raise Recession Fears, and Point Fingers at the Fed

Treasury Secretary Scott Bessent said some sectors were in a recession as he argued for more interest rate cuts.
The Workers Left Out of Trump’s Drug-Manufacturing Renaissance

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.